Conestoga Capital Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Conestoga Capital Advisors’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-706,606	Closed	-$57.8M	–	148
2021 Q2	$57.8M	Sell	706,606 -88,291	-11%	-$7.23M	0.84%	46
2021 Q1	$75.6M	Sell	794,897 -353,556	-31%	-$33.6M	1.14%	40
2020 Q4	$71.3M	Buy	1,148,453 +11,288	+1%	+$700K	1.14%	42
2020 Q3	$67.6M	Buy	1,137,165 +58,718	+5%	+$3.49M	1.36%	37
2020 Q2	$75.2M	Buy	1,078,447 +38,736	+4%	+$2.7M	1.64%	32
2020 Q1	$47.2M	Buy	1,039,711 +46,407	+5%	+$2.11M	1.38%	39
2019 Q4	$64.6M	Sell	993,304 -20,904	-2%	-$1.36M	1.56%	36
2019 Q3	$63M	Sell	1,014,208 -6,420	-0.6%	-$399K	1.61%	31
2019 Q2	$72.7M	Buy	1,020,628 +25,155	+3%	+$1.79M	1.82%	25
2019 Q1	$78.1M	Buy	995,473 +215,080	+28%	+$16.9M	2.17%	18
2018 Q4	$66.1M	Sell	780,393 -127,262	-14%	-$10.8M	2.1%	22
2018 Q3	$155M	Buy	907,655 +103,119	+13%	+$17.7M	3.97%	1
2018 Q2	$104M	Buy	804,536 +50,276	+7%	+$6.5M	3.35%	1
2018 Q1	$77.7M	Sell	754,260 -30,937	-4%	-$3.19M	2.98%	3
2017 Q4	$67.1M	Buy	785,197 +90,898	+13%	+$7.76M	2.58%	14
2017 Q3	$59M	Buy	694,299 +75,751	+12%	+$6.43M	2.61%	10
2017 Q2	$46.8M	Buy	618,548 +40,227	+7%	+$3.05M	2.44%	14
2017 Q1	$38.2M	Buy	578,321 +31,663	+6%	+$2.09M	2.31%	17
2016 Q4	$34.7M	Buy	546,658 +2,492	+0.5%	+$158K	2.31%	16
2016 Q3	$34.6M	Buy	544,166 +40,428	+8%	+$2.57M	2.37%	16
2016 Q2	$37.5M	Sell	503,738 -158,881	-24%	-$11.8M	2.77%	11
2016 Q1	$44.3M	Buy	662,619 +203,901	+44%	+$13.6M	2.99%	10
2015 Q4	$31M	Sell	458,718 -36,208	-7%	-$2.45M	2.51%	14
2015 Q3	$26.4M	Sell	494,926 -18,260	-4%	-$976K	2.12%	25
2015 Q2	$32.3M	Sell	513,186 -8,544	-2%	-$538K	2.24%	19
2015 Q1	$25.1M	Sell	521,730 -7,366	-1%	-$354K	1.72%	31
2014 Q4	$17.6M	Buy	529,096 +59,326	+13%	+$1.97M	1.22%	37
2014 Q3	$13.8M	Buy	469,770 +78,691	+20%	+$2.31M	1.01%	43
2014 Q2	$15.2M	Buy	+391,079	New	+$15.2M	1.02%	44